Drug Shortage Report for SCOPOLAMINE HYDROBROMIDE INJECTION

Last updated on 2019-03-23 History
Report ID 66030
Drug Identification Number 02242810
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.4MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1 mL vial
ATC code N05CM
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-01-02
Actual start date
Estimated end date 2019-03-31
Actual end date 2019-03-22
Shortage status Resolved
Updated date 2019-03-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-03-23 English Compare
v10 2019-03-22 French Compare
v9 2019-03-22 English Compare
v8 2019-01-03 English Compare
v7 2018-12-17 French Compare
v6 2018-12-17 English Compare
v5 2018-12-17 French Compare
v4 2018-12-17 English Compare
v3 2018-11-02 English Compare
v2 2018-11-01 French Compare
v1 2018-11-01 English Compare

Showing 1 to 11 of 11